Submitted by Anonymous (not verified) on 11 September 2026 - 15:03
Human medicines European public assessment report (EPAR): Emgality, galcanezumab, Date of authorisation: 14/11/2018, Revision: 15, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Emgality, galcanezumab, Date of authorisation: 14/11/2018, Revision: 15, Status: Authorised